Diplomat named to ICIC and Fortune’s Inner City 100; among the nation’s fastest-growing inner city businesses
FLINT, Mich. — Nov. 5, 2014— Diplomat Pharmacy, Inc. (NYSE:DPLO), the nation’s largest independent specialty pharmacy, is proud to announce that the company has been named to the Inner City 100 list. The annual competition, held by Initiative for a Competitive Inner City, seeks to celebrate urban entrepreneurship by recognizing the fastest-growing businesses headquartered in America’s inner cities, as measured by revenue growth between 2009 and 2013.
The 2014 competition selected 10 businesses in each of 10 industry sectors: construction, manufacturing, professional services, food & beverage, retail, media and communications, software and information technology, transportation and logistics, health care and biotechnology, and arts, entertainment and recreation. Diplomat ranked 6th in the health care and biotechnology sector and landed 69th overall. Diplomat was one of five Michigan companies recognized on the 2014 list.
Companies selected were honored at the Inner City 100 Symposium and Awards, held Oct. 15 − 16, 2014 in Boston, Massachusetts. Additionally, the Inner City 100 list is published annually in Fortune.
Founded in 1994 by Harvard Business professor Michael Porter, the ICIC strengthens inner city economies by providing actionable information about marketing opportunities in urban areas. Learn more about the ICIC’s efforts to support inner city businesses by visiting www.icic.org
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients, and the rest falls into place.” Today, that tradition continues – always focused on improving patient care and clinical adherence. For more information visit www.diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.
Abigail Bearman, Diplomat
810.768.9563 | firstname.lastname@example.org
@DiplomatRx@JNJNews treatment Zytiga significantly cut the death risk for ... prostate cancer patients by 38% https://t.co/6Ga1okf4Ye @ASCO #ASCO173 days ago
@sloan_ketteringRT @sloan_kettering: Your immune system provides one of the best defenses against cancer. But sometimes it needs a little help. More about…1 week ago
@DiplomatRxThank you to @corpmagazine for recognizing Diplomat as a 2017 Michigan Economic Bright Spot awardee!2 weeks ago
@DiplomatRxFriend and Patient Advocate, Brenda Williams Hawkes was featured in @MyGoodDays Days this month!… https://t.co/TFGSoMecqO2 weeks ago
@DiplomatRxJeff Park Elected to Diplomat Board of Directors https://t.co/IMI1aRwNbm2 weeks ago